Cargando…
Gallbladder cancer harboring ERBB2 mutation on the primary and metastatic site: A case report
BACKGROUND: Bile duct cancer constitutes gallbladder cancer (GBC), intrahepatic cholangiocarcinoma (ICA), and extrahepatic cholangiocarcinoma (ECA). These three entities show morphological and immunohistochemical resemblance so that it is difficult to differentiate between primary ICA and liver meta...
Autores principales: | Inagaki, Chiaki, Maeda, Daichi, Kimura, Akie, Otsuru, Toru, Iwagami, Yoshifumi, Nishida, Naohiro, Sakai, Daisuke, Shitotsuki, Ryo, Yachida, Shinichi, Doki, Yuichiro, Satoh, Taroh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755105/ https://www.ncbi.nlm.nih.gov/pubmed/31558980 http://dx.doi.org/10.4251/wjgo.v11.i9.761 |
Ejemplares similares
-
Nivolumab-induced interstitial lung disease in a patient with gastric cancer
por: Kimura, Akie, et al.
Publicado: (2019) -
Clinical Utility of Next-Generation Sequencing-Based Panel Testing under the Universal Health-Care System in Japan: A Retrospective Analysis at a Single University Hospital
por: Inagaki, Chiaki, et al.
Publicado: (2021) -
The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy
por: Inagaki, Chiaki, et al.
Publicado: (2023) -
Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis
por: Koseki, Jun, et al.
Publicado: (2018) -
Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells
por: Konno, Masamitsu, et al.
Publicado: (2018)